International Journal of Oral Biology

The Korean Academy of Oral Biology (대한구강생물학회)
권호 표지

Anti-proliferative and Anti-telomerase Activity of Curcuma Rhizome Extract on Oral Squamous Cell Carcinoma and Osteosarcoma Cells

  • Kim, Kyung-Jin (Department of Oral Biochemistry College of Dentistry, Kyung Hee University) ;
  • Kim, Jeong-Hee (Department of Oral Biochemistry College of Dentistry, Kyung Hee University)
  • Published : 2007.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Anti-proliferation of methanol extract of Curcuma rhizome on oral squamous cell carcinoma (KB) and osteosarcoma (HOS) cells were investigated. In order to elucidate the involvement of telomerase inhibitory activity as a part of anti-proliferative effect of Curcuma rhizome on cancer cells, we measured telomerase activity in Curcuma rhizome extract-treated cancer cells. The concentration inhibited cell proliferation to 50% $(IC_{50})$ of the methanol extract of Curcuma rhizome against oral squamous cell carcinoma (KB) cells and osteosarcoma (HOS) cells were 21.30 ${\mu}g/ml$ and 39.3${\mu}g/ml$, respectively. The methanol extract of Curcuma rhizome showed inhibitory telomerase inhibitory effect which is required for cancer cell immortality. Therefore, it seems that the anticancer effect of methanol extract of Curcuma rhizome is at least partially due to telomerase inhibitory effect. Five fraction samples were prepared according to its polarity differences and analyzed anti-proliferative effects of each fraction samples on oral squamous cell carcinoma and osteosarcoma cells. Anticancer effect was observed in dichloromethane, and ethylacetate fractions. The highest anticancer effect was found in dichloromethane fraction which had $IC_{50}$ value of 23.3 ${\mu}g/ml$ and 10.5${\mu}g/ml$ against oral squamous cell carcinoma (KB) cells and osteosarcoma (HOS) cells, respectively.

Keywords

References

  1. Akiyama, M., Hideshima, T., Munshi, N. C., Anderson, K. C.:Telomerase inhibitors as anticancer therapy. Curr, Med. Chem. Anticancer Agents 2: 567-575, 2002 https://doi.org/10.2174/1568011023353778
  2. Allsopp, R. C., Vaziri, H., Patterson. C., Goldstein, S., Younglai, E.V., Futcher, A.B., Greider, C.W. and Harley, C.B.: Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 89: 10114-10118, 1992
  3. Al-Sarraf, M., Pajak, T. F., Marcial, V. A., Mowry, P., Cooper, J. S., Stetz, J., Ensley, J. F. and Velez-Garcia, E.: Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG study. Cancer 59: 259-265, 1987
  4. Blackburn, E.H.: Structure and function of telomeres. Nature 350: 569-573, 1991 https://doi.org/10.1038/350569a0
  5. Boring, C. C., Squires, T. S. and Tong, T.: Cancer statistics. CA Cancer J. Clin. 42: 19-38, 1992 https://doi.org/10.3322/canjclin.42.1.19
  6. Giridharan, P., Somasundaram, S. T., Perumal, K., Vishwakarma, R. A., Karthikeyan, N. P., Velmurugan, R., Balakrishnan, A.: Novel substituted methylenedioxy lignan suppresses proliferation of cancer cells by inhibiting telomerase and activation of c-myc and caspases leading to apoptosis. Br. J. Cancer 87: 98-105, 2002 https://doi.org/10.1038/sj.bjc.6600422
  7. Kang, S. C., Lee, C. M., Choi, H., Lee, J. H., Oh, J. S., Kwak, J. H. and Zee, O. P.: Evalution of oriental medicinal herbs for estrogenic and antiproliferative activities. Phytother Res 20: 1017-1019, 2006 https://doi.org/10.1002/ptr.1987
  8. Kelland, L. R.: Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects. Eur. J. Cancer 41: 971-979, 2005 https://doi.org/10.1016/j.ejca.2004.11.024
  9. Kish, J.A., Weaver, A., Jacobs, J., Cummings, G and Al-Sarraf, M.: Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 53: 1819-1824, 1984 https://doi.org/10.1002/1097-0142(19840501)53:9<1819::AID-CNCR2820530903>3.0.CO;2-R
  10. Kojima, H., Yanai, T. and Toyota, A.: Essential oil constituents from Japanese and Indian Curcuma aromatica rhizomes. Planta. Med. 64: 380-381, 1998 https://doi.org/10.1055/s-2006-957458
  11. Lee, J. H. and Kim, M. J.: Chemosensitivity of cisplatin and 5-fluorouracil on oral squamous cell carcinoma cell lines. J. Kor. Assoc. Oral Maxillofac. Surg. 24: 165-171, 1998
  12. Lee, S. C. and Kim, Y. G.: Oral and Maxillofacial Oncology, Jisung, Seoul, 1993
  13. Lee, Y. H., Kim, Y. G. and Kim, J. H.: Studies on anti-oral cancer activities of medicinal plant extracts. J. Kor. Assoc. Oral Maxillofac. Surg. 26: 53-58, 2000
  14. Liu, J. J., Wu, X. Y., Lul, H. L., Pan, X. L., Peng, J. and Huang, R. W.: Anti-proliferation effect of oridonin on HL-60 cells and its mechanism. Chin. Moo. Sci. J. 19: 134-137, 2004
  15. Mallery, S. R., Stoner, G. D., Larsen, P. E., Fields, H. W., Rodrigo, K. A., Schwartz, S. J., Tian, Q., Dai, J. and Mumper, R. J.: Formulation and in-vitro and in-vivo evaluation of a mucoadhesive gel containing freeze dried black raspberries: implications for oral cancer chemoprivention. Pharm. Res. 24: 728-737, 2007 https://doi.org/10.1007/s11095-006-9192-1
  16. Manoharan, S., Kavitha, K., Senthil, N. and Renju, G.L.: Evaluation of anti carcinogenic effects of clerodendron inerme on 7, 12-dimethylbenz(a) anthracene-induced hamster buccal pouch carcinogenesis. Singapore Med. J. 47: 1038-1043, 2006
  17. Miyoshi, Y., Tsukinoki, K., Imaizumi, T., Yamada, Y., Ishizaki, T., Watanabe, Y., Sasakura, Y., Lin, Y., Hosaka, M. and Kubota, Y.: Telomerase activity in oral cancer. Oral Oncol. 35: 283-289, 1999 https://doi.org/10.1016/S1368-8375(98)00117-1
  18. Mutirangura, A., Supiyaphun, P., Trirekapan, S., Sriuranpong, V., Saknntabhai, A., Yenrudi, S. and Voravud, N.: Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. Cancer Res. 56: 3530-3533, 1996
  19. Olaussen, K. A., Dubrana, K., Domont, J., Spano, J. P., Sabatier, L. and Soria, J. C.: Telomere and telomerase as targets for anticancer drug development. Crit. Rev. Oncol. Hematol. 57: 191-214, 2006 https://doi.org/10.1016/j.critrevonc.2005.08.007
  20. Peterson, L. J., Indresano, A. T., Marciani, R. D. and Roser, S. M.: Principles of oral and maxillofacial surgery. J. B. Lippincott, Philadelphia, 1992
  21. Rhyu, M. S.: Telomeres, telomerase, and immortality. J. Natl. Cancer Inst. 87: 884-894, 1995 https://doi.org/10.1093/jnci/87.12.884
  22. Silverman, S. J. and Gorsky, M.: Epidermiologic and demographic update in oral cancer: California and national data-1973 to 1985. J. Am. Dent. Assoc. 120: 495-499, 1990 https://doi.org/10.14219/jada.archive.1990.0082
  23. Suto, A., Kubota, J. and Shimoyama, Y.: MTT assay with reference to the clinical effect of chemosensitivity. J. Surg. Oncol. 42: 28-32, 1989 https://doi.org/10.1002/jso.2930420108
  24. Tohda. C., Nakayama, N., Hatanaka. F. and Komatsu. K.: Comparison of anti-inflammatory activities of six Curcuma Rhizomes: A possible Curcuminoid-independent pathway mediated by Curcuma phaeocaulis extract. Evid. Based Complement Alternat. Med. 3: 255-260, 2006 https://doi.org/10.1093/ecam/nel008
  25. Zimmermann. S. and Martens, U. M.: Telomeres and telomerase as targets for cancer therapy. Cell Mol. Life Sci. 64: 906-921, 2007 https://doi.org/10.1007/s00018-007-6481-8